Nuclear Imaging Equipment Market Size & Growth Forecast 2026–2035, By Segments (Modality, Application, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Nuclear Imaging Equipment Market size stood at USD 6.7 Billion in 2025 and is predicted to grow at a 3.4% CAGR from 2026 to 2035, reaching USD 9.36 Billion by 2035. The industry revenue for 2026 is estimated at USD 6.89 billion.
Get more details on this report
Request Free Sample ReportNuclear Imaging Equipment Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 45.39% of the market in 2025, driven by advanced diagnostic imaging infrastructure, steady equipment replacement demand, and continued investment in nuclear medicine across major clinical applications.
- Asia Pacific is expected to grow at a 3.88% CAGR as healthcare providers expand diagnostic services, invest in imaging infrastructure, and integrate nuclear imaging into routine clinical care.
Segment Momentum
- SPECT accounted for a 60.77% share in 2025 due to its broad clinical adoption, established diagnostic workflows, extensive installed base, and continued replacement demand across healthcare facilities.
- Cardiology is the fastest-growing application as providers increasingly adopt functional imaging to support earlier cardiac assessment and more targeted treatment decisions for cardiovascular conditions.
Market Expansion Drivers
- Rising global cancer prevalence driving demand for PET and SPECT diagnostic imaging systems.
- Advancements in PET and SPECT imaging technologies improving diagnostic precision and workflow efficiency.
- Expanding healthcare infrastructure investment increasing nuclear imaging equipment deployment in hospitals.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Key players in the nuclear imaging equipment market include GE HealthCare Technologies Inc. (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), United Imaging Healthcare Co., Ltd. (China), Mediso Medical Imaging Systems Ltd. (Hungary), Fujifilm Holdings Corporation (Japan), Cubresa Inc. (Canada), Neusoft Medical Systems Co., Ltd. (China).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
As cancer incidence rises, clinicians are relying more heavily on PET and SPECT systems to detect tumors earlier, stage disease more accurately, and monitor treatment response with greater confidence than conventional imaging alone can often provide. This is driving demand for the nuclear imaging equipment market because oncology care pathways increasingly require functional imaging at multiple points, from initial diagnosis through therapy assessment and recurrence surveillance. Hospitals and diagnostic centers respond by expanding installed capacity, upgrading older scanners, and prioritizing systems that can handle higher oncology volumes while integrating with multidisciplinary cancer programs.
Advancements in PET and SPECT imaging technologies improving diagnostic precision and workflow efficiency
Technology improvements in detector sensitivity, image reconstruction, hybrid imaging integration, and scan-time optimization are reshaping purchasing decisions in the nuclear imaging equipment market by making PET and SPECT systems more clinically productive and easier to justify operationally. Providers are not only seeking sharper images for difficult cases, but also equipment that improves throughput, reduces repeat scans, and supports more standardized interpretation across busy radiology and nuclear medicine departments. That combination strengthens market development by linking clinical value directly to equipment utilization, staffing efficiency, and the broader push toward more streamlined diagnostic workflows.
Expanding healthcare infrastructure investment increasing nuclear imaging equipment deployment in hospitals
Investment in hospital construction, specialty care expansion, and diagnostic modernization is translating into more procurement opportunities for the nuclear imaging equipment market, particularly where health systems are building out advanced imaging capabilities rather than relying on referral-based access. Nuclear imaging equipment is often introduced as part of broader capital planning for oncology, cardiology, and tertiary care services, since hospitals need in-house imaging to support faster clinical decisions and retain higher-acuity patients. This practical shift from limited access to embedded imaging capacity is increasing market penetration as more institutions allocate space, shielding, technical staff, and supporting radiopharmaceutical handling infrastructure needed to operate PET and SPECT platforms.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising global cancer prevalence driving demand for PET and SPECT diagnostic imaging systems | 2.20% | High | North America, Europe | High | Near Term |
| Advancements in PET and SPECT imaging technologies improving diagnostic precision and workflow efficiency | 1.90% | High | North America, Asia Pacific | High | Mid Term |
| Expanding healthcare infrastructure investment increasing nuclear imaging equipment deployment in hospitals | 1.70% | High | Asia Pacific, Latin America | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held the leading regional position in 2025, accounting for a 45.39% share of the nuclear imaging equipment market. This leadership is supported by the region’s established diagnostic imaging infrastructure, broad installed base of advanced hospital and outpatient imaging systems, and steady replacement demand for aging equipment. In practice, market activity is supported by healthcare providers’ ongoing investment in high-performance imaging platforms, along with the clinical reliance on nuclear medicine for oncology, cardiology, and neurology applications across mature care settings.
Asia Pacific is projected to register a 3.88% CAGR over the forecast period in the nuclear imaging equipment market, driven by expanding access to advanced diagnostic services and continued investment in healthcare capacity. Growth is accelerating as more providers integrate nuclear imaging into routine clinical pathways, particularly in large population centers where demand for earlier and more accurate disease detection is rising. The region’s momentum is also supported by the gradual build-out of imaging infrastructure, which is increasing equipment deployment across both established urban hospitals and developing healthcare networks.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Imaging InfrastructureGermany focuses on expanding high-performance nuclear imaging capabilities across university hospitals and specialized diagnostic centers. Demand in Germany is supported by investment in hybrid imaging technologies and efficient equipment utilization for complex clinical applications.
France 🇫🇷
Hospital Modernization FocusFrance continues investing in modernization of nuclear imaging departments to improve diagnostic capacity across public healthcare facilities. Procurement priorities in France increasingly favor reliable systems with efficient imaging performance, lower maintenance requirements, and compatibility with multidisciplinary care pathways.
Italy 🇮🇹
Diagnostic Capacity ExpansionItaly is expanding access to modern nuclear imaging equipment through hospital upgrades and regional healthcare investments. Medical providers in Italy are prioritizing dependable imaging technologies that enhance diagnostic workflows while supporting efficient operation within established healthcare facilities.
Japan 🇯🇵
Aging Care DiagnosticsJapan places strong emphasis on nuclear imaging equipment that supports oncology, neurology, and cardiovascular diagnostics for an aging population. Healthcare institutions in Japan continue modernizing imaging systems while seeking compact, high-efficiency technologies that fit existing clinical infrastructure.
South Korea 🇰🇷
Digital Imaging IntegrationSouth Korea is strengthening adoption of nuclear imaging equipment through digitally connected hospitals and advanced diagnostic workflows. Healthcare providers in South Korea increasingly favor systems that combine high-resolution imaging with streamlined data integration and clinical efficiency.
United States 🇺🇸
Advanced Clinical AdoptionThe U.S. nuclear imaging equipment market emphasizes replacement of aging imaging systems with advanced PET and SPECT platforms that improve diagnostic accuracy and workflow efficiency. Healthcare providers in the U.S. also prioritize integration with digital imaging networks and AI-enabled image analysis.
Segment Leadership and Growth Trends
Nuclear Imaging Equipment Market Share (%), Modality, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportSPECT held the dominant position in the nuclear imaging equipment market in 2025, accounting for a 60.77% share. Its leadership is maintained through broad clinical adoption, established use across routine diagnostic workflows, and the practical advantage of being deeply integrated into hospital and imaging center operations. In the nuclear imaging equipment market, SPECT remains the modality with the widest installed base, which supports continued equipment utilization, replacement demand, and physician familiarity.
PET is the fastest-growing modality in the nuclear imaging equipment market because providers are increasingly prioritizing imaging systems that support more advanced diagnostic precision, especially in cases where earlier and clearer disease characterization is critical. Its momentum is rising relative to SPECT as healthcare facilities expand capabilities for high-value imaging applications and align equipment investment with evolving clinical expectations for more detailed functional assessment.
Application Segment Analysis: Oncology (Largest Segment) vs Cardiology (Fastest-Growing Segment)
Within the nuclear imaging equipment market, oncology led the application segment in 2025 with a 51.93% share. This leadership reflects the central role of nuclear imaging in cancer detection, staging, treatment planning, and disease monitoring, where repeat imaging and high diagnostic dependence sustain equipment demand. Oncology maintains its dominant share in the nuclear imaging equipment market because cancer care pathways rely heavily on imaging-supported decision-making across multiple points of treatment.
Cardiology is emerging as the fastest-growing application in the nuclear imaging equipment market as demand strengthens for functional imaging that can support earlier assessment of cardiac conditions and more informed management of patient risk. Growth is outpacing other applications because cardiovascular evaluation increasingly depends on imaging tools that help clinicians move beyond structural assessment and guide treatment decisions in a more targeted way.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Modality | SPECT, PET | SPECT | PET |
| Application | Cardiology, Oncology, Neurology, Others | Oncology | Cardiology |
| End-use | Hospitals, Imaging Centers, R&D, Others | Hospitals | R&D |
Competitive Landscape and Market Positioning
1. GE HealthCare Technologies Inc. (United States)
2. Siemens Healthineers AG (Germany)
3. Koninklijke Philips N.V. (Netherlands)
4. Canon Medical Systems Corporation (Japan)
5. United Imaging Healthcare Co. Ltd. (China)
6. Mediso Medical Imaging Systems Ltd. (Hungary)
7. Fujifilm Holdings Corporation (Japan)
8. Cubresa Inc. (Canada)
9. Neusoft Medical Systems Co. Ltd. (China)
The nuclear imaging equipment market is transforming through the integration of artificial intelligence and advanced visualization technologies into diagnostic imaging systems. Market participants are focusing on improving scan efficiency, image clarity, and workflow automation to support faster and more accurate clinical decision-making. Demand for early disease detection and precision diagnostics is also encouraging continuous innovation in imaging equipment capabilities.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Shanghai United Imaging Healthcare Co., LTD. | Jul-24 | Shanghai United Imaging Healthcare installed its first PET/CT scanner in Mexico at the Instituto Nacional de Pediatría, marking an expansion of its advanced nuclear imaging footprint into Latin America. The deployment reflects growing international adoption of the company’s diagnostic imaging systems and strengthens its presence in emerging healthcare markets focused on upgrading molecular imaging infrastructure. |
| GE Healthcare | Jun-24 | GE Healthcare introduced the MINItrace Magni compact cyclotron to enable in-house production of PET tracers and radiometals, supporting decentralized radiopharmaceutical workflows. The system is positioned to enhance hospital autonomy in tracer supply and improve operational efficiency across nuclear medicine departments by reducing dependency on external isotope suppliers and improving imaging workflow reliability. |
| GE Healthcare | Jun-24 | GE Healthcare launched the Omni Legend 21 cm PET/CT system designed to address rising demand for high-performance molecular imaging. The system targets improved diagnostic throughput and image quality across diverse clinical settings, reinforcing GE Healthcare’s portfolio expansion in advanced PET/CT solutions for oncology and cardiology imaging applications. |
| GE Healthcare | Jun-24 | GE Healthcare introduced Clarify DL, a deep learning-based reconstruction technology aimed at improving PET/CT image clarity and diagnostic accuracy. The solution integrates AI-driven processing to enhance image consistency and reduce noise, supporting more efficient interpretation workflows and strengthening GE Healthcare’s position in software-enabled nuclear imaging innovation. |
| GE Healthcare | Feb-24 | GE Healthcare entered a three-year collaboration with MedQuest Associates to enhance multi-site outpatient imaging network performance. The initiative focuses on integrating advanced imaging technologies with operational infrastructure to improve patient care delivery, optimize workflow efficiency, and strengthen scalability across distributed diagnostic imaging centers in outpatient healthcare environments. |
| Koninklijke Philips N.V. | May-23 | Philips, Elekta, and Mercurius Health signed a three-year agreement to deploy diagnostic and therapeutic oncology equipment and integrated informatics solutions at the newly acquired Robert Janker Klinik cancer center in Germany. The initiative supports modernization of oncology imaging and treatment infrastructure within a consolidated clinical care environment. |
| Mediso Ltd | Apr-22 | Mediso Ltd acquired Bartec Technologies Ltd, a UK-based provider of nuclear medicine and molecular imaging equipment distribution and support services. The acquisition strengthens Mediso’s commercial and service capabilities in the UK and Ireland, enhancing its regional market penetration and expanding its installed base support infrastructure in nuclear imaging systems. |
| Siemens Healthineers | Jun-22 | Siemens Healthineers launched the Symbia Pro.specta SPECT/CT system, integrating advanced SPECT and CT imaging capabilities. The system received CE mark and FDA clearance and features low-dose CT technology with up to 64-slice imaging, supporting improved diagnostic precision and reinforcing Siemens’ portfolio in hybrid nuclear imaging systems. |
| Canon Inc. | Nov-22 | Canon established Canon Healthcare USA, Inc. to expand its medical business operations in the United States. The new subsidiary strengthens Canon’s strategic positioning in the North American healthcare imaging market and supports broader commercialization of its medical imaging technologies, including nuclear and diagnostic imaging solutions. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Nuclear Imaging Equipment Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Nuclear Imaging Equipment Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow large is the nuclear imaging equipment market?
How will the nuclear imaging equipment industry grow in terms of size and CAGR by 2035?
How are technology advancements shaping procurement strategies in the nuclear imaging equipment market?
Why is healthcare infrastructure expansion accelerating demand for nuclear imaging equipment?
Why is SPECT the leading modality in the nuclear imaging equipment market?
Which application is expanding fastest in the nuclear imaging equipment market?
Why is North America the largest nuclear imaging equipment market?
How is Asia Pacific expanding in the nuclear imaging equipment market?
Who holds a significant market share in the nuclear imaging equipment landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization